MedWatch

Novo Nordisk will use computer models for diabetes drug discovery

Danish Novo Nordisk has entered a research collaboration with an Oxford-based biotech company that uses artificial intelligence and advanced computer models for drug discovery. During the next year, the companies will look for new treatments of a "specific area of type-2 diabetes".

Foto: /ritzau/Stine Tidsvilde

Novo Nordisk hopes to identify new treatment options for the lifestyle disease type 2 diabetes, and for that purpose the Danish drug group has entered a research collaboration with UK-based biotech company E-Therapeutics.

E-Therapeutics is located in Oxford, UK, and employs 20 people. The company has developed a special technology platform for identifying drug-like molecules by use of computer models and artificial intelligence.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier